secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2026-01-27T23:59:59+00:00
Accession:  0001193125-26-024431
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inovio extends Series A Warrant expiration to March 31, 2026
------------------------------------------------------------

- Amendment extends expiration of Series A Warrants (up to 13,564,268 shares) from Jan 28, 2026 to March 31, 2026.
- Warrants issued in July 2025 public offering; exercise price $1.75/share (pre-funded at $0.001).
- Original expiration was 30 days after FDA BLA acceptance for INO-3107; extension provides additional exercise window.
- All other warrant terms remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312526024431/0001193125-26-024431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312526024431/d63939d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-024431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer